chrisvoncsefalvay/vaers-outcomes huggingface dataset:
9/24 - got first dose of pfizer. 15 min or so after getting shot, didn?t feel right.  Head felt strange, faint, chest tightness/pressure, palpitations, throat felt swollen, weakness/pain/tingling down left arm, left hand aching, panicky feeling.  Severe symptoms lasted about an hour; chest tightness/aching and left arm/hand issues subdued but never went away.    That weekend - bouts of the same episode above after putting anything in my body.  Coffee, ibuprofen, eating food.  Chest tightness/pressure and left arm/hand issues continued ongoing.  Palpitations and panicky feeling come and go.  Rash/sores on my face; cold sore on my lip.  Extremity weakness, dizziness, periods of fatigue and then surging energy (like waking up at night with enough energy to clean the whole house).  Left hand and eye begin twitching.  Overall, just feeling awful and knowing something isn?t right.  Seem sensitive to everything; can?t eat or do things as normal.  Stopped drinking coffee or taking any medication.  9/27 - call w/dr.  Prescribed vistiril and xanax.    Took Vistaril the next 5 days.  Helped in that it made me groggy and could just go to sleep.  Skin rash/sores begin to immediately clear up.  Once med would wear off, all the same issues above come back.  Left hand/eye twitching getting worse.  10/1 - mentally slow processing/foggy, hyper-sensitive to noise and motion, difficulty conversing with people/understanding what they?re saying, hallucinations (seeing shadows), felt like I was going out of my mind, woke up that night with severe cramping/spasms in left hand, spasms in forehead/eyes/right side of face, couldn?t feel left side of face, same heart issues.  Sharp pains in back of head.  Stopped taking vistaril  10/2 - struggled through day with heart issues and body spasms; left hand/eye pretty constant, but differ in severity.  Woke up again at night with spasms/head pressure/ pain  10/3 - called to see about going to hospital; went to urgent care.  Dr. wants all this reported to vaccine registry; thinks having an autoimmune reaction. Didn?t think Guillain Barre at this point.  Echo scheduled for 10/19  The next week - same issues waxing and waning.  Heart issues much more subdued.  Spasms migrated to right side of body (last about 10-15 min in other areas); feet/hands/arms/eyes, but most severe on left side.  The above issues waxed and waned for a solid month after getting vaccine before really starting to subdue.  To date, still having issues with sensitivities (can't tolerate weak coffee or alcohol, certain foods), fatigue/weakness, occasional spasms/tremors, chest pain/tightness.  Symptoms seem to relapse if do too much of normal routine.
took the first dose of vaccine and arm is swelling; fever; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration on Apr2021 (Batch/Lot Number: Unknown) as single dose for covid-19 immunisation. The patient medical history and patient's concomitant medications were not reported. Patient stated took the first dose of vaccine and arm was swelling and patient was feeling not bad but next day afternoon like more than 24 hours later patient got the fever. The event outcome for events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Dose interval more than 42 days; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose interval more than 42 days) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy (PCN).   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Aug-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose interval more than 42 days). On 23-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose interval more than 42 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant drugs were reported.  No Treatment information  were reported   Most recent FOLLOW-UP information incorporated above includes: On 24-Aug-2021: Added second dose onset date Event Inappropriate schedule of vaccine administration and narrative was update accordingly.
48 y.o. female who presented with peristomal skin irritation. Ostomy nursing evaluated the patient and taught her how to use a new appliance. Diet was advanced to regular diet and patient was taking sufficient PO intake to maintain hydration.Patient was ambulating. The patient was deemed stable for discharge on 8/14/22.
Zoster rash to R forehead extending down to eyelid/nasal bridge, worsening over the course of 3 days.
Pt was here to rec'd vaccine. Pt rec'd rec'd Pfizer 0.3ml IM rt arm. When documenting vaccine. It was noted that pt had already rec'd two doses of Moderna.
Fever 102+, 12-hour duration, used Tylenol.  Soreness from 24-48 hrs, felt better after 2-days.  I was notified that the second dose was not temperature controlled, will need a 3rd dose next week.
Patient became hot, dizzy and lightheaded.  Placed supine on cart, observed x 40 minutes.  Initial BP 180/70 HR 74  Sat 100.   F/U BP 182/73  HR 77  sat 100%.    Provided water and cold pack.  Systems resolved ~ 15 minutes and patient denies further complaints. Last BP 170/68  HR 76 sat 100%
Patient presented to the ED 5/18/21  with voice slurring, headache, leg swelling.  Patient with symptoms starting on Friday 5/14/21.  Patient with profound weakness of her lower extremities, unable to ambulate around the house which is new.  Patient also reporting she feels "different/wrong."  While here in the Emergency department, patient fell onto her rear while at ultrasound, did not hit her head.  Unable to stand on her own after.    Patient was found to have an acute left lower extremity DVT on 5/17/21:  Acute deep venous thrombosis throughout the left lower extremity with most proximal extension of thrombus into the common femoral vein noting that the external iliac vein could not be visualized
I got the shot for a new job. A few hours after I got the shot I started experiencing chills. Those lasted all week. I also had a headache, sore muscles, and a fever. A week after I got the shot, I passed out. From that fall I got a concussion. I also ended up in the ER the night of my passing out because I was experiencing intense muscle spasms/convulsions. The shot also aggravated other issues that I went to the doctor for and it turns out they're symptoms of Chronic Lyme disease. So the flu shot brought out Lyme symptoms that I hadn't experienced in the past.
small erythematous non-tender papule @ injection site-raised wheel & flare looking areas. Hives over body-possibly secondary  to DTaP
Patient received a dose of MODERNA 6 month- 5 years Covid-19 vaccine today. He should have received a dose of PFIZER 5-11 years Covid-19 vaccine, as that was the product used as the first dose in the series, on 07/22/2022. No physical reaction.
had a flu like/sick feeling for 3 days; sick feeling for 3 days, didn't feel well; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 76-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious), outcome "recovered", described as "had a flu like/sick feeling for 3 days"; MALAISE (non-serious), outcome "unknown", described as "sick feeling for 3 days, didn't feel well". Additional information: It was reported patient received the primary series and one booster shot from Pfizer. Patient had two covid shot and had one booster back in Mar from her local Pharmacy. Patient wanted to know more about the Pfizer Bivalent vaccine and stated that she went to the pharmacist and was told there is another booster dose. She had side effects with the first two covid vaccines and 1 booster. She had a flu like/sick feeling for 3 days. Patient clarified that she was not allergic to the previous vaccine doses but 7-8 hours later she didn't feel well and a couple of days later. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt's 11 year old vaccines (HPV, Tdap, MCV4) were administered by RN with him sitting on the end of the exam table at approximately 8:30. Tdap and MCV4 were administered in the left arm, HPV last in the right arm. The RN walked away instantly and pt. fainted instantly, fell face first off the exam table and hit his head extremely hard on the ground feet from the RN?s feet who was throwing things away. Pt then appeared to seize for about 5 seconds according to his pediatrician (but the ER dr. and paramedics later said it was just a reaction to the concussion), and went unconscious for 5-10 seconds.  Dr. Office monitored pt. for over 2 hours on the exam room floor with a pulse that would get faint at times and every time he got up he got dizzy and would sweat profusely and was very clammy. Dr. Office called EMS after 2 hours and he was taken by ambulance to hospital. He was diagnosed with Vasovagal Syncope and a Concussion with loss of consciousness. They never did do a CT Head scan.  The CDC indicates that ?Fainting and related injuries after immunizations can be prevented. Many falls due to fainting can be prevented by having the patient sit or lie down.  For this reason, experts recommend having patients sit in a chair or lay down when they receive a vaccination.  In addition, patients should be observed for 15 minutes after vaccination.?  Clinic did not follow this recommendation. It appears safety protocol was not followed to prevent injury from a possible fainting episode.  They had pt seated upright on the end of the exam table and the nurse walked away immediately after the 3rd poke (which was the HPV vaccination). Dr. had mom engaged in conversation on the computer with their backs turned to pt. I believe clinic should make protocol improvements to prevent this from happening again in the future and that they are responsible for not following simple vaccine safety precautions that could have prevented pt. from getting hurt. As Dr. herself stated that this happened under their watch and she has reported it. Dr. acknowledged that this incident shouldn?t have happened and could have been prevented. She shared that their clinic is going to use it as a learning situation. A nurse whom I spoke with on 7/3/2023 said that as a result of pt.s incident, reminder email went out to remind all staff on what protocol should be followed for positioning of shots. It should be 45 degree angle in bed or in a seated chair with arms. Nurse did say that this was always the protocol, but it was missed that day with pt. and she apologized.
The lot number for the first dose of vaccine that I received on 01/05/2021 is 026L20A, and the lot number for the second dose of vaccine that I took on 02/02/2021 is 028L20A. After I got both shots I has soreness but after the second shot the pain in the injection site never went away. my whole left arm is sore and the fatigue from my arm migrated over to my chest. My chest was very weak. the soreness or fatigue is also in my legs, thighs calves, hamstrings. and  my arms and legs are still fatigued and I have a hard time moving around.
I have not received my 2nd dose yet; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I have not received my 2nd dose yet) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]), LOSARTAN POTASSIUM (COZAAR), LEVOTHYROXINE, CELECOXIB (CELEBREX), MONTELUKAST SODIUM (SINGULAIR), HYDROCODONE BITARTRATE, PARACETAMOL (NORCO), BUPROPION HYDROCHLORIDE (WELLBUTRIN), FLUOXETINE HYDROCHLORIDE (PROZAC), SOLIFENACIN SUCCINATE (VESICARE) and CLONIDINE for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I have not received my 2nd dose yet). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I have not received my 2nd dose yet) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Due to bad weather in the month of February the patient could not schedule her second dose of vaccine. No treatment information was provided.
lupus; Fibromyala; itchy; suffering with them now,; haven't had a good night sleep; hurt/ neck scalp are the worse; hurt; This case was reported by a consumer via media and described the occurrence of systemic lupus erythematosus in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced systemic lupus erythematosus (serious criteria GSK medically significant), fibromyalgia, pruritus, shingles, difficulty sleeping, scalp pain and pain. On an unknown date, the outcome of the systemic lupus erythematosus, fibromyalgia, pruritus, shingles, difficulty sleeping, scalp pain and pain were not recovered/not resolved.   It was unknown if the reporter considered the systemic lupus erythematosus, fibromyalgia, pruritus, shingles, difficulty sleeping, scalp pain and pain to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient was suffering with shingles at the time of reporting, and had a lot of pain and itchy, also had lupus and fibromyalgia this was no joke. The patient did not have a good night sleep in 5 days, shingles seem to hurt and itch at night, in neck scalp were the worse. The patient stated he/she had one part of the shot and hoped if he/she could get the rest of it when this gets better. The follow-up would not possible as no contact details were available.
This spontaneous report was received from a physician refers to a 1 year old patient (gender unknown). No medical history was reported. On 23-MAY-2013, the patient was vaccinated with an expired dose of M-M-R II (lot # 670619/0601AA, expiry: 26-APR-2013). This is 1 of 2 reports regarding twin patients (siblings) received from the same reporter. Additional information has been requested.
red mark the size of a half dollar at the injection site, with some swelling,; Injection site, with some felt hard; Sore arm; Slight headache; Fatigue; Administered the vaccine subcutaneously at a 45 degree angle rather than intramuscular as recommended; Red mark the size of a half dollar at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via subcutaneous route of administration in the left arm on 13Apr2021 at 14:45 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included citalopram (MANUFACTURER UNKNOWN) and ethinylestradiol; levonorgestrel (KURVELO). On 13Apr2021 at 14:45, the patient was administered the vaccine subcutaneously at a 45-degree angle rather than intramuscular as recommended and the patient developed a red mark the size of a half dollar at the injection site, with some swelling, and it feels hard, also had a sore arm, slight headache and fatigue. The patient stated that, she was concerned about potential side effects from the vaccine being subcutaneously injected as well as the efficacy this first dose will now have. She had video evidence of the injection happening & have spoken to and shown the video to numerous medical professionals and pharmacists who all agree this is an incorrect injection that should be reported. She contacted the establishment in which she received the vaccine and they advised that they are not concerned and will not be reporting this incident to VAERS even though the CDC website specifically states that it must be reported. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events vaccine subcutaneously at a 45-degree angle rather than intramuscular as recommended, developed a red mark the size of a half dollar at the injection site, with some swelling, and it feels hard, also had a sore arm, slight headache and fatigue was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Upon injection pt momentarily fainted:  Eyes closed, body slumped.  Eye lids fluttered open & pt began to cry saying her "ears hurt".  Laid pt. down - applied cool paper towels to forehead.  Pt rested & felt better after Approx 15 min.
The batch of vaccine that was getting prepared was not diluted properly, one vial out of seventeen was not diluted. It is unknown if that person received this vaccine administration. This was also reported to Pfizer.  Patient informed of possible dilution error and counseling provided. The client waited 30 minutes post vaccination without adverse reaction. Medical advisor given notice of incident and advised client to call his HCP with any concerns.
4 hrs after vaccination itching & redness at injection site, irritation present also. At 8 hrs shot site 3" diameter of swelling, itching, redness; also sinus congestion and feet itching top of feet bilaterally lasting about 72 hrs.
Acute hepatitis diagnosis; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 55-year-old male patient received BNT162b2 (BNT162B2), on 18May2022 at 11:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 55 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: LISINOPRIL. Vaccination history included: Covid-19 vaccine (Manufacturer: Unknown, Dose number: 03), for Covid-19 immunization; Covid-19 vaccine (Manufacturer: Unknown, Dose number: 02), for Covid-19 immunization; Covid-19 vaccine (Manufacturer: Unknown, Dose number: 01), for Covid-19 immunization. The following information was reported: HEPATITIS ACUTE (hospitalization, medically significant) with onset 24May2022 at 08:00, outcome "not recovered", described as "Acute hepatitis diagnosis". The patient was hospitalized for hepatitis acute (hospitalization duration: 7 day(s)). The event "acute hepatitis diagnosis" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (01Aug2022) Negative, notes: COVID test post vaccination. Therapeutic measures were taken as a result of hepatitis acute.  Clinical course: No other vaccine in four weeks. Other medications in two weeks included Lisinopril. No COVID prior vaccination. Tested for covid after vaccination. No known allergies and no other medical history. Adverse event included acute hepatitis diagnosis 6 days post vaccination and adverse event resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization. Treatment included Steroids.    The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information provide and plausible temporal association, the causality between BNT162B2 and events cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
PATIENT EXPERIENCED PAIN IN HEAD EXTENDING INTO NECK, SHOOTING PAIN IN STOMACH, NAUSEA, AND SORENESS IN THE ARM OF INJECTION SITE.  ALSO HAD DIFFICULTY WITH COGNITIVE FUNCTION AND FELT INCAPACITATED.  WENT TO BED WITH SYMPTOMS WHICH DID NOT RESOLVE UNTIL 3PM ON SUNDAY, 08/29/2021. PATIENT FEELS OK NOW.  I INFORMED PATIENT TO REPORT TO HER PCP.
on the third day of the application he felt pain in his torax on the left side,; oppressive and a sensation of shortness of breath; oppressive; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (on the third day of the application he felt pain in his torax on the left side,), DYSPNOEA (oppressive and a sensation of shortness of breath) and SENSE OF OPPRESSION (oppressive) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (on the third day of the application he felt pain in his torax on the left side,), DYSPNOEA (oppressive and a sensation of shortness of breath) and SENSE OF OPPRESSION (oppressive). At the time of the report, CHEST PAIN (on the third day of the application he felt pain in his torax on the left side,), DYSPNOEA (oppressive and a sensation of shortness of breath) and SENSE OF OPPRESSION (oppressive) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment details were provided.
could not urinated went to ER had Catheter put in, 24 hours later blood clots in Catheter bag and was in hospital for 10 days
This spontaneous report as received from a medical assistant refers to a 26 year old male patient with attention deficit/hyperactive disorder. The patient had no drug reactions or allergies. On 31-JUL-2014 the patient was vaccinated with the first dose of GARDASIL (lot # K001500, expiration date 06-NOV-2016, dose 0.5 ml, intramuscular in the left arm). Concomitant therapies included ADDERALL. On 01-AUG-2014 the patient experienced extensive swelling and bruising of the entire left upper arm. The upper arm swelling was to "3 times its normal size". The swelling and bruising resolved on 07-AUG-2014 without requiring medical treatment. The medical assistant added that the patient would not be administered any further doses of GARDASIL. No lab diagnostics studies were performed. The patient had sought medical attention via calling the office. It was reported that the patient was given the last dose on 31-JUL-2014. Additional information has been requested.